Nicotine given independently from tobacco may help ward off Parkinson’s or Alzheimer’s disease. It is a common knowledge that tobacco and tobacco products are bad for your health, but new research findings suggest that nicotine alone...Show More Summary
A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical Center. The findings of the study of nearly 1,000 older adults were published in the Sept. 30 issue of the journal, Brain.
Chances are good that you personally know someone who has, or at one time had, dementia. Alzheimer’s disease, the most well-known form of dementia, is the sixth-leading cause of death in the United States and the current number of diagnosed...Show More Summary
“When I jumped out, it was me taking control back in this awful disease and not letting it get me down."
Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer's disease.
It's over a hundred years since the first case of Alzheimer's disease was diagnosed. Since then we've learned a great deal about the protein 'tangles' and 'plaques' that cause the disease. How close are we to having effective treatments -- and could we even prevent dementia from occurring in the first place?
Tau PET is a new and promising imaging method for Alzheimer’s disease. A case study in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs.
The National Institutes of Health (NIH) has awarded Wake Forest Baptist Medical Center a grant worth an estimated $8.7 million over five years for the establishment of a new center for research into Alzheimer's disease.
Scientists have established a rough outline of how Alzheimer's disease takes hold, and bit by bit they are starting to fill in the details. Key players in this process are what are known as amyloid beta proteins which form in clumps, evolve into plaques and cause irreversible damage to the brain. Show More Summary
More than 5 million Americans are living with Alzheimer’s disease, and the number is expected to triple in another 35 years.
Experts spoke with LiveScience about the biggest mysteries of Alzheimer's disease.
Does Marijuana Hold the Cure for Alzheimer’s? This article was originally published on the Motley Fool. The statistics associated with Alzheimer’s disease are downright depressing. The disease, which typically affects the elderly and is characterized by a progressive decline in...
This article was originally published on the Motley Fool. The statistics associated with Alzheimer's disease are downright depressing. The disease, which typically affects the elderly and is characterized by a progressive decline inShow More Summary
Mediterranean diet slows cognitive decline rate and Alzheimer’s disease in older adults. So far the Mediterranean diet has been hailed for its heart health benefits, but much research has also shown its benefits for the brain. The Mediterranean...Show More Summary
County Executive Rushern L. Baker III’s wife suffers from Alzheimer’s disease.
United States: A new report estimated that one million Latinos are expected to be diagnosed with Alzheimer's Disease by 2030, which could lead to a cash crunch for families who “are among the least resourced to deal with the financial...Show More Summary
Recent studies have shown that the quality and atmosphere of buildings can slow the progression of Alzheimer's disease and dementia and promote good health. The therapeutic features and overall design of the innovative new Alzheimer Village in France was created with this idea in mind. Show More Summary
With the baby boomers’ generation aging, the cases of Alzheimer’s disease, which can cause memory loss, are growing in numbers. According to a report released by Alzheimer’s Association, over 28 million baby boomers will develop Alzheimer’s...Show More Summary
(Reuters) - Danish drugmaker H Lundbeck A/S said its late-stage study testing an experimental drug to treat mild tomoderate Alzheimer's disease failed.
A vast class of incurable neurodegenerative disorders are characterized by the aggregation and deposition of aberrant proteins like the amyloid bpeptide or the a-synuclein, considered to be a factor behind the development of Alzheimer's and Parkinson's diseases, respectively. Show More Summary